| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
88,020,000 |
| Market
Cap: |
1.89(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$14.07 - $36.68 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 6.1 |
| Insider 6 Months : 9.3 |
| Insider 3/6 Months : 15.8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Zai Lab is a holding company. Through its subsidiaries, Co. is a commercial-stage biopharmaceutical company focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of unmet medical need in the China and global markets, including in the fields of oncology, infectious and autoimmune diseases. Co.'s products are: Niraparib, a selective oral, small molecule PARP 1/2 inhibitor with the potential to be a drug for treatment across multiple solid tumor types in China; and Optune, a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
3,000 |
12,000 |
12,000 |
12,000 |
| Total Buy Value |
$62,490 |
$316,740 |
$316,740 |
$316,740 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
3 |
3 |
3 |
| Total Shares Sold |
29,642 |
66,991 |
66,991 |
101,576 |
| Total Sell Value |
$507,370 |
$1,486,369 |
$1,486,369 |
$2,828,455 |
| Total People Sold |
6 |
6 |
6 |
8 |
| Total Sell Transactions |
11 |
15 |
15 |
21 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Edmondson Frazor Titus Iii |
Chief Legal Officer |
• – – |
2023-06-23 |
4 |
OE |
$25.30 |
$369,380 |
D/D |
14,600 |
36,547 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-06-23 |
4 |
D |
$25.30 |
$585,391 |
D/D |
(23,138) |
1,079,051 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-06-23 |
4 |
OE |
$25.30 |
$1,487,640 |
D/D |
58,800 |
1,055,913 |
|
- |
|
| Cho William Ki Chul |
Chief Financial Officer |
• – – |
2023-04-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,827 |
53,747 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-06 |
4/A |
D |
$40.55 |
$4,902,738 |
D/D |
(120,906) |
994,089 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-06 |
4/A |
OE |
$0.60 |
$180,000 |
D/D |
300,000 |
1,114,995 |
|
- |
|
| Edmondson Frazor Titus Iii |
Chief Legal Officer |
• – – |
2023-03-06 |
4 |
AS |
$40.55 |
$322,981 |
D/D |
(7,965) |
19,400 |
|
-30% |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
852 |
994,089 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,906) |
994,941 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
300,000 |
1,115,847 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-03 |
4/A |
GD |
$0.00 |
$0 |
D/D |
852 |
814,995 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2023-03-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
43,128 |
815,847 |
|
- |
|
| Lis William |
Director |
– • – |
2023-03-03 |
4 |
AS |
$38.31 |
$208,177 |
D/D |
(5,434) |
23,330 |
|
-30% |
|
| Vounatsos Michel |
Director |
– • – |
2023-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
18,332 |
18,332 |
|
- |
|
| Reinhart Harald |
See Remarks |
• – – |
2023-03-03 |
4 |
AS |
$40.00 |
$459,200 |
D/D |
(11,480) |
18,958 |
|
-30% |
|
| Reinhart Harald |
See Remarks |
• – – |
2023-03-03 |
4 |
OE |
$3.00 |
$34,440 |
D/D |
11,480 |
30,438 |
|
- |
|
| Amado Rafael |
See Remarks |
• – – |
2022-12-30 |
4 |
A |
$0.00 |
$0 |
D/D |
126,000 |
126,000 |
|
- |
|
| Reinhart Harald |
See Remarks |
• – – |
2022-12-30 |
4 |
D |
$30.70 |
$181,222 |
D/D |
(5,903) |
18,958 |
|
- |
|
| Wirth Peter |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.33 |
$141,320 |
I/I |
(4,000) |
0 |
|
-3% |
|
| Wirth Peter |
Director |
– • – |
2022-12-08 |
4 |
S |
$35.37 |
$136,245 |
D/D |
(3,852) |
342,763 |
|
-3% |
|
| Reinhart Harald |
See Remarks |
• – – |
2022-11-15 |
4 |
AS |
$40.00 |
$74,163 |
D/D |
(1,854) |
24,861 |
|
-9% |
|
| Reinhart Harald |
See Remarks |
• – – |
2022-11-15 |
4 |
OE |
$3.00 |
$5,562 |
D/D |
1,854 |
26,715 |
|
- |
|
| Edmondson Frazor Titus Iii |
Chief Legal Officer |
• – – |
2022-08-17 |
4 |
D |
$43.52 |
$51,397 |
D/D |
(1,181) |
7,965 |
|
- |
|
| Edmondson Frazor Titus Iii |
Chief Legal Officer |
• – – |
2022-08-17 |
4 |
OE |
$43.52 |
$211,072 |
D/D |
4,850 |
9,146 |
|
- |
|
| Du Ying |
Chairperson & CEO |
• • – |
2022-06-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
120,000 |
858,975 |
|
- |
|
182 Records found
|
|
Page 3 of 8 |
|
|
1.44 (7.17%) 
